Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2003Critical Care Medicine

Targeting high mobility group box 1 as a late-acting mediator of inflammation

View Full Paper
Ask AI
Bookmark
Share

Authors

CCChristopher J. CzuraUniversity of Maryland, Baltimore
Kevin J. Tracey
Kevin J. TraceyBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Czura et al. (2003) studied this question.

synapsesocial.com/papers/6ab1ce804515ffbb2befc18ehttps://doi.org/10.1097/00003246-200301001-00007
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation2002 · 593 citations
  2. 2HMG-1 REDISCOVERED AS A CYTOKINE2001 · 145 citations
  3. 3Specific Recognition of Cruciform DNA by Nuclear Protein HMG11989 · 611 citations
  4. 4Ringer’s ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats2001 · 210 citations